You have 9 free searches left this month | for more free features.

Leukemia

Showing 26 - 50 of 9,158

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Lyon, France
    Centre Léon Bérard
Nov 30, 2023

A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia

Not yet recruiting
  • C-KIT Mutation
    • (no location specified)
    Nov 2, 2023

    Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Mitoxantrone hydrochloride liposome injection
    • +3 more
    • (no location specified)
    May 29, 2023

    T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

    Recruiting
    • T Lymphoblastic Leukemia/Lymphoma
    • Hangzhou, Zhejiang, China
      The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
    Aug 7, 2023

    Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • (no location specified)
    Jul 10, 2023

    Leukemia Trial in Alexandria (Peppermint Inhalation, Swedish Massage)

    Completed
    • Leukemia
    • Peppermint Inhalation
    • Swedish Massage
    • Alexandria, Egypt
      Eman Arafa Badr
    Oct 17, 2023

    Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

    Suspended
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • (no location specified)
    Nov 22, 2023

    B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • HY004
    • +2 more
    • (no location specified)
    Aug 18, 2023

    Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Mitoxantrone hydrochloride liposome injection
    • +3 more
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jul 1, 2023

    T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

    Not yet recruiting
    • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    • CD7-CART01
    • (no location specified)
    Sep 26, 2023

    Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

    Not yet recruiting
    • Chronic Myelogenous Leukemia - Chronic Phase
    • APN and medical management
    • +3 more
    • Avignon, Provence-Alpes-Côte d'Azur, France
      Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
    Oct 13, 2023

    Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)

    Not yet recruiting
    • Lymphoblastic Leukemia
    • Palo Alto, California
      Stanford University
    Apr 27, 2023

    Chronic Myelomonocytic Leukemia Trial in Indianapolis (CD4CAR)

    Not yet recruiting
    • Chronic Myelomonocytic Leukemia
    • CD4CAR
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Oct 2, 2023

    Acute Myeloid Leukemia Trial in Taipei

    Enrolling by invitation
    • Acute Myeloid Leukemia
      • Taipei, Taiwan
        National Taiwan University Hospital
      Aug 9, 2023

      B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

      Recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • QH103 Cell Injection
      • +2 more
      • Hefei, Anhui, China
        Anhui Provincial Hospital
      Sep 21, 2023

      Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

      Not yet recruiting
      • Chronic Myelogenous Leukemia
      • Houston, Texas
        The University of Texas MD Anderson Cancer Center
      Oct 12, 2023

      Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

      Completed
      • Multiple Myeloma
      • Chronic Lymphocytic Leukemia
      • Myeloma Coach or CLL Coach Mobile App
      • Springboard Beyond Cancer informational website
      • Durham, North Carolina
        Duke University
      Jun 23, 2023

      CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

      Not yet recruiting
      • CLL
      • (no location specified)
      Oct 3, 2023

      Anti-mullerian Hormone in Acute Lymphoblastic Leukemia

      Recruiting
      • Acute Lymphoblastic Leukemia
        • Trieste, Italy
          IRCCS Burlo Garofolo
        Mar 20, 2023

        Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

        Not yet recruiting
        • Chemotherapy-Induced Thrombocytopenia
        • Hetrombopag Olamine
        • (no location specified)
        Jul 5, 2023

        PET Tracer Based FDG Signal for Predicting Prognosis in Acute

        Enrolling by invitation
        • Acute Myeloid Leukemia
        • No intervention
        • Guangzhou, Guangdong, China
          First Affiliated Hospital of Jinan University
        Jun 22, 2023

        Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia Trial in Tianjin (LILRB4 STAR-T cells injection)

        Not yet recruiting
        • Acute Myelogenous Leukemia
        • Chronic Myelomonocytic Leukemia
        • LILRB4 STAR-T cells injection
        • Tianjin, Tianjin, China
        • +1 more
        Feb 12, 2023

        Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Trial in Xi'an (Olverembatinib plus venetoclax and dexamethasone)

        Recruiting
        • Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
        • Olverembatinib plus venetoclax and dexamethasone
        • Xi'an, Shannxi, China
          Department of Hematology, Xijing Hospital, Fourth Military Medic
        Oct 9, 2023

        B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

        Recruiting
        • B-Cell Non Hodgkin Lymphoma
        • B-Cell Acute Lymphoblastic Leukemia
        • anti-CD19 CAR T-cells
        • Hanoi, Vietnam
          Vinmec Research Institute of Stem Cell and Gene Technology
        Sep 5, 2023